OVERVIEW

15th Annual Clinical Trials Summit 2024 is organized by Virtue Insight and will be held from May 29 - 30, 2024 at Kohinoor Continental, Mumbai, Maharashtra, India.

Description:
15th Annual Clinical Trials Summit 2024 will provide a platform to discuss on the futuristic advancements in Clinical Trials and clinical research. This multidisciplinary program involves broad participation of people from Clinical Trials community who are focused on learning more about clinical research, Clinical Trials planning & management. This event opens discussion of timely topics of mutual theoretical and practical interest for clinical trial investigators who are developing new drugs and biologics. This groundbreaking platform continues the conversation between business, academics, patient advocacy, and regulatory agencies to discuss new methods and solutions to statistical challenges relevant to the design and analysis of Clinical Trials collaboratively in the real world. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.

It gives us immense pleasure in welcoming you to the 15th Annual Clinical Trials Summit 2024. I wish and pray that all our efforts will be beneficial to our industries and to our country at large.

KEY SPEAKERS:

  • MAYUR PARMAR, Drugs Inspector (Deputy Collector, Gujarat Government), FDA
  • SUYOG MEHTA, VP & Head - Medical Affairs & Clinical Research, India & Emerging Markets, Sun Pharma
  • ANIL KUKREJA, VP - Medical Affairs & Regulatory, AstraZeneca
  • SANDESH SAWANT, VP Medical Affairs & Head - Clinical Trials, Cipla
  • RAMESH JAGANNATHAN, Vice President, Medical Affairs, Bharat Serums and Vaccines
  • SHALINI MENON, Country Medical Director, South Asia, Sanofi
  • ANIRBAN ROY CHOWDHURY, AVP & Head- Global CoE for Clinical Data Management Biostatistics & Clinical Operations, Sun Pharma
  • VAIBHAV SALVI, Director & Head – Clinical Study Unit, India & South East Asia, Sanofi
  • RASHMI HEGDE, VP Medical Affairs, GSK
  • SHIRAZ KANDAWALLA, Associate Director Regulatory Affairs, Ferring Pharmaceuticals
  • VIPIN SETHI, Asst Vice President, Cadila
  • CHIRAG TRIVEDI, Global Head, Clinical Study Units (CSU) Early Operational Strategy, Sanofi
  • MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates
  • ANITHA K, Global Head Operations, GDO Data Operations, Novartis
  • YASMIN SHENOY, Director-Regulatory Affairs, Sanofi
  • ANUP PINGLE, Medical Director - Global Health Access, GSK
  • MUKESH GORI, Director ESP Engagement PV & PS, Novartis
  • DIVAKAR KOLLI, Director - Development Quality Assurance, Cipla
  • SUCHITA MORE, Associate Director Medical Affairs, MSD
  • ASHWANI PANDITA, GM Quality Management & Training, Global Clinical Research Operations, Glenmark Pharmaceuticals
  • VIVEK GUPTA, Associate Director - Strategic Engagements & Vendor Management - Clinical & Medical Affairs, Organon
  • SAKSHI SHRIVASTAVA DESAI, Associate Director International PV Strategy Realization, Johnson & Johnson
  • DILIP PAWAR, Director & Head Clinical Development and Medical Affairs, Unichem Laboratories
  • KAMLESH PATEL, Head - Medical Regulatory Clinical Research & Health Tech, Lupin
  • ROSHAN PAWAR, Head Medical Affairs, Alkem Laboratories
  • KEDAR NAYAK, Head - Clinical Development, GSK
  • INDU NAMBIAR, Head PV, Local Patient Safety Lead, Boehringer Ingelheim
  • SADANAND KULKARNI, Head - Medical, Regulatory, Vigilance & Quality (South Asia), Fresenius Kabi
  • DEVEN BABRE, Former Director Analytics & Benchmarking, GSK
  • RENUKA NEOGI, Head & Deputy General Manager – Global Clinical Quality Management, Sun Pharma
  • PRIYA CHATTERJEE, Head Regulatory Affairs - South Asia, Bayer Pharmaceuticals
  • VISHVAJIT M. KARANDIKAR, Business Unit (BU) Head -Parenteral Nutrition, Fresenius Kabi
  • NISHITH VYAS, Associate Director, R&D Strategic Sourcing and Vendor Management, Organon
  • GOPINATH MADHU, Senior Client Partner, Digital & Technology, Pfizer
  • SANKET NEWALE, Head Medical Affairs & Business Compliance, Wockhardt
  • MAYUR MAYBHATE, Head Medical Affairs, Alkem Laboratories
  • GODHULI CHATTERJEE, Senior Medical Advisor, India-South East Asia, Sanofi
  • INDRANIL PURKAIT, Senior GM -Medical Affairs, Ipca Laboratories
  • KAVITA LAMROR, Partner, RWE & Digital Transformation, Maxis Clinical
  • SHRADDHA BHANGE, Senior Medical Safety Lead, Sandoz
  • PRAVIN GHADGE, AVP and Head - India clinical research, Sun Pharma Laboratories
  • SEERA DILEEP RAJU, Senior Manager - ML & AI, MSD
  • KUSHAL SARDA, GM & Head, Medical Affairs, Clinical Research & PV, Shalina Healthcare
  • VISHWAS SOVANI, Founder Director, Pharmawisdom
  • VANDAN TRIPATHI, Sr Brand Manager (Digital), Cipla

Plus more joining soon

KEY THEMES:

  • Clinical Trials – Market Analysis: Opportunities & Challenges
  • Why Decentralisation is the future of Clinical Trials?
  • Decentralisation - Sustaining DCT adoption in a challenging economic environment
  • Challenges and risks for launching decentralized trials
  • Prioritising patients – Always placing patients first
  • Improving collaboration & transparency: The need for strong sponsor-vendor relationships
  • Clinical Trial Supply - What’s the new way forward?
  • Innovative methods for Clinical trial design
  • Inspection readiness - What to expect when you’re inspected?
  • Rising opportunities & challenges for a successful clinical trial management
  • How RWE / RWD is transforming Clinical Trials? Challenges & Opportunities?
  • Technology & Innovation – Impacts & Improvements on Patient Experience
  • Explore the Impact of DCT on clinical development & the evolution of audits
  • Creating an effective clinical trial site management
  • Outsourcing in clinical trials: How to build successful partnerships?
  • Collaborations between CROs and the Pharmaceutical Industry
  • Data Integrity and Data Management
  • End-to-end strategic partnership & managing communication gap in CROs
  • Ratification - New Drugs and Clinical Trial Rules 2023
  • What regulatory changes & developments can help in advancement of Clinical Trials in India
  • Be part of a major networking opportunity

SPONSORS:
Exhibitor - Clinical Research Network India

We have more sponsorship opportunities available for the event, which gives you an opportunity to exhibit/booth/speak and create brand awareness.

KEY DATES

Event Start Date
29 May, 2024
Event Start Date
Event End Date
30 May, 2024
Event End Date

TARGET AUDIENCE

Clinical ResearchersClinical TrialsClinical OperationsClinical PharmacologyClinical Data ManagementRegulatory affairsMedical AffairsSafety SurveillanceCEOs, CFOs, CMOs, CMIOs, CIOs, & CNOs

SPECIALITIES

Clinical PharmacologyResearch and Clinical Research

SUGGESTED HOTELS

CONFERENCE VENUE

LocationKohinoor Continental
Andheri - Kurla Rd, J B Nagar, Andheri East

RELATED CONFERENCES & LIVE WEBINARS

icons

Aug 21, 2026 | Washington, Dist...

State required course for Illinois ...
14 CE/CME
More actions
US$995

Jul 23 - 24, 2026 | Vienna, Wien, AT

Research and Clinical Research
More actions
AT€350

Nov 12 - 14, 2026 | Orlando, Florida, USA

State required course for Illinois ...
37 CME/CE
More actions
US$2,295